Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
19.01
+1.73 (10.01%)
May 23, 2025, 2:45 PM CST
SHE:002727 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 22, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 10,914 | 7,625 | 13,803 | 18,782 | 22,959 | 19,830 | Upgrade
|
Market Cap Growth | -34.50% | -44.76% | -26.51% | -18.19% | 15.78% | 50.15% | Upgrade
|
Enterprise Value | 10,722 | 7,679 | 13,717 | 19,101 | 23,481 | 18,129 | Upgrade
|
Last Close Price | 19.01 | 13.02 | 22.72 | 30.46 | 36.64 | 31.47 | Upgrade
|
PE Ratio | 338.01 | 66.80 | 25.12 | 18.60 | 24.91 | 25.10 | Upgrade
|
Forward PE | 29.68 | 10.17 | 13.00 | 16.59 | 19.48 | 22.86 | Upgrade
|
PS Ratio | 0.62 | 0.42 | 0.79 | 1.08 | 1.57 | 1.57 | Upgrade
|
PB Ratio | 1.42 | 1.00 | 1.75 | 2.50 | 3.44 | 3.43 | Upgrade
|
P/TBV Ratio | 2.05 | 1.44 | 2.33 | 3.20 | 4.52 | 4.37 | Upgrade
|
P/FCF Ratio | 7.82 | 5.20 | 7.41 | 8.74 | 16.40 | 26.33 | Upgrade
|
P/OCF Ratio | 6.46 | 4.43 | 6.53 | 7.52 | 12.81 | 19.19 | Upgrade
|
PEG Ratio | - | 1.10 | 1.10 | 1.10 | 1.10 | 1.10 | Upgrade
|
EV/Sales Ratio | 0.61 | 0.43 | 0.79 | 1.10 | 1.61 | 1.43 | Upgrade
|
EV/EBITDA Ratio | 6.95 | 15.58 | 14.16 | 13.34 | 18.30 | 18.51 | Upgrade
|
EV/EBIT Ratio | 35.97 | 20.04 | 16.25 | 14.50 | 19.81 | 20.15 | Upgrade
|
EV/FCF Ratio | 7.68 | 5.24 | 7.37 | 8.89 | 16.77 | 24.07 | Upgrade
|
Debt / Equity Ratio | 0.40 | 0.40 | 0.38 | 0.41 | 0.44 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 2.00 | 1.86 | 1.50 | 1.33 | 1.28 | 0.06 | Upgrade
|
Debt / FCF Ratio | 2.21 | 2.07 | 1.61 | 1.44 | 2.08 | 0.08 | Upgrade
|
Asset Turnover | 1.02 | 1.08 | 1.06 | 1.14 | 1.23 | 1.46 | Upgrade
|
Inventory Turnover | 3.07 | 3.13 | 3.26 | 3.43 | 3.38 | 3.89 | Upgrade
|
Quick Ratio | 0.74 | 0.70 | 0.80 | 0.82 | 0.70 | 1.15 | Upgrade
|
Current Ratio | 1.30 | 1.27 | 1.37 | 1.38 | 1.31 | 1.90 | Upgrade
|
Return on Equity (ROE) | 0.36% | 1.42% | 7.28% | 14.27% | 14.73% | 15.21% | Upgrade
|
Return on Assets (ROA) | 1.08% | 1.43% | 3.21% | 5.40% | 6.26% | 6.50% | Upgrade
|
Return on Capital (ROIC) | 1.69% | 2.22% | 4.91% | 8.15% | 9.61% | 10.30% | Upgrade
|
Return on Capital Employed (ROCE) | 3.20% | 4.20% | 8.90% | 14.20% | 14.00% | 15.50% | Upgrade
|
Earnings Yield | 0.30% | 1.50% | 3.98% | 5.38% | 4.01% | 3.98% | Upgrade
|
FCF Yield | 12.79% | 19.22% | 13.49% | 11.44% | 6.10% | 3.80% | Upgrade
|
Dividend Yield | 1.74% | 2.30% | 1.76% | 1.31% | 0.82% | 0.95% | Upgrade
|
Payout Ratio | 806.83% | 228.27% | 47.40% | 18.97% | 19.63% | 22.15% | Upgrade
|
Buyback Yield / Dilution | 1.26% | 0.76% | -0.27% | -0.50% | -3.32% | -0.88% | Upgrade
|
Total Shareholder Return | 3.00% | 3.06% | 1.49% | 0.81% | -2.50% | 0.07% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.